Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 131 participants.
Also called NCT05293002
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 131 participants
- Sponsor
- Registry
-
NCT05293002
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Unknown status
Technical summary
Registry record NCT05293002. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06-13 (actual); primary completion 2025-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.
- Acronym
- BARISTA
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Restorer Iliac Stent System
- Lead sponsor
- ID3 Medical
Record details
- Record id
cardio:ct-nct05293002- Content hash
341966865e70444dcd0125a25d701b558a3f90b36d2ea913c76c62483ee3ac56